BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8180114)

  • 1. Inhibition of steroid sulphatase activity by steroidal methylthiophosphonates: potential therapeutic agents in breast cancer.
    Purohit A; Howarth NM; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):523-7. PubMed ID: 8180114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
    Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
    Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells.
    Purohit A; Dauvois S; Parker MG; Potter BV; Williams GJ; Reed MJ
    J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):101-4. PubMed ID: 8049127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate.
    Purohit A; Williams GJ; Roberts CJ; Potter BV; Reed MJ
    Int J Cancer; 1995 Sep; 63(1):106-11. PubMed ID: 7558436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid sulfohydrolase in human chorion and decidua: studies using pregnenolone sulfate and dehydroepiandrosterone sulfate as substrate.
    Chibbar R; Mitchell BF
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1693-701. PubMed ID: 2140834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.
    Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ
    Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity.
    Purohit A; Vernon KA; Hummelinck AE; Woo LW; Hejaz HA; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):269-75. PubMed ID: 9618028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
    Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ
    Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells.
    MacIndoe JH
    Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of breast cyst fluid on oestrone sulphatase activity in MCF-7 breast cancer cells.
    Erbas H; Lennard TW; Lai LC
    Anticancer Res; 1996; 16(2):833-6. PubMed ID: 8687137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast-cancer cells: modulation by steroidal and non-steroidal therapeutic agents.
    Purohit A; Reed MJ
    Int J Cancer; 1992 Apr; 50(6):901-5. PubMed ID: 1532568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylsulphatase C and sterol sulphatase activities in microsomes from human placenta.
    Gniot-Szulzycka J
    Acta Biochim Pol; 1982; 29(3-4):205-12. PubMed ID: 6961709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the development of steroid sulphatase inhibitors.
    Purohit A; Hejaz HA; Woo LW; van Strien AE; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 1999; 69(1-6):227-38. PubMed ID: 10418996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and steroid sulphatase inhibitory activity of C19- and C21-steroidal derivatives bearing a benzyl-inhibiting group.
    Ciobanu LC; Boivin RP; Luu-The V; Poirier D
    Eur J Med Chem; 2001; 36(7-8):659-71. PubMed ID: 11600235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells.
    Selcer KW; Kabler H; Sarap J; Xiao Z; Li PK
    Steroids; 2002 Sep; 67(10):821-6. PubMed ID: 12231117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radioimmunoassay for plasma dehydroepiandrosterone sulphate incorporating placental steroid sulphatase as a hydrolysing reagent.
    France JT; Jackson W; Keelan J
    J Steroid Biochem; 1986 Sep; 25(3):375-8. PubMed ID: 2945968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of oestrogen synthesis in postmenopausal women with breast cancer.
    James VH; Reed MJ; Purohit A
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):149-53. PubMed ID: 1525057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor.
    Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ
    Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
    Purohit A; Malini B; Hooymans C; Newman SP
    Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovine placental steroid 17 alpha-hydroxylase/C-17,20-lyase, aromatase and sulphatase in dexamethasone-induced and natural parturition.
    Mason JI; France JT; Magness RR; Murry BA; Rosenfeld CR
    J Endocrinol; 1989 Jul; 122(1):351-9. PubMed ID: 2788698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.